Arzoxifene - CAS 182133-25-1
Catalog number: 182133-25-1
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C28H29NO4S
Molecular Weight:
475.60
COA:
Inquire
Targets:
Estrogen Receptor/ERR
Description:
Arzoxifene, also known as LY353381, a synthetic aromatic derivative with anti-estrogenic properties, displays greater bioavailability and higher anti-estrogenic potency in the breast than another selective estrogen receptor modulators (SERMs),raloxifene.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Related CAS:
182133-25-1(free base); 182133-27-3(HCl salt)
Appearance:
Solid powder
Synonyms:
2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol; 4'F-DMA; 182133-27-3 (hydrochloride salt); arzoxifene; LY 353381; LY-353381; LY353381
MSDS:
Inquire
InChIKey:
MCGDSOGUHLTADD-UHFFFAOYSA-N
InChI:
InChI=1S/C28H29NO4S/c1-31-22-8-5-20(6-9-22)28-27(25-14-7-21(30)19-26(25)34-28)33-24-12-10-23(11-13-24)32-18-17-29-15-3-2-4-16-29/h5-14,19,30H,2-4,15-18H2,1H3
Canonical SMILES:
COC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)OCCN5CCCCC5
Current Developer:
Eli Lilly
1.Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial.
Arantes HP1, Kulak CA, Fernandes CE, Zerbini C, Bandeira F, Barbosa IC, Brenol JC, Russo LA, Borba VC, Chiang AY, Bilezikian JP, Lazaretti-Castro M. Osteoporos Int. 2013 Oct;24(10):2707-12. doi: 10.1007/s00198-013-2366-x. Epub 2013 Apr 30.
SUMMARY: We investigated vitamin D status in Brazilian cities located at different latitudes. Insufficiency (<50 nmol/L) was common (17 %), even in those living in a tropical climate. Vitamin D insufficiency increased as a function of latitude. Mean 25-hydroxyvitamin D (25(OH)D) levels in each site and latitude correlation were very high (r = -0.88; p=0.02). [corrected].
2.Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene Generations Trial.
Arantes HP1, Gimeno SG2, Chiang AY3, Bilezikian JP4, Lazaretti-Castro M1. Arch Endocrinol Metab. 2016 Feb;60(1):54-9. doi: 10.1590/2359-3997000000141.
Objective Vertebral fracture is the most common osteoporotic fracture, affecting quality of life and increasing mortality. Epidemiological data on incidence of vertebral fracture are scarce in Brazil and throughout Latin America. Our aim was to determine vertebral fracture incidence and risk factors in a female Brazilian population. Subjects and methods Postmenopausal women with low bone mass were studied from the Brazilian placebo group of Arzoxifene Generations Trial (n = 974), followed for up to 5 years. The primary endpoint was new vertebral fractures, detected by X-Ray. Experimental design defined two strata: A. Osteoporosis or previous vertebral fracture with osteopenia; B. Osteopenia without previous fracture. Previous fracture, T-score, ionized calcium, alkaline phosphatase, creatinine and glucose were analyzed at baseline. Crude and adjusted incidence rates of vertebral fractures were estimated and Poisson regression model was used.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Estrogen Receptor/ERR Products


BHPI
(CAS: 56632-39-4)

BHPI is an antagonist of estrogen receptor α (ERα), for it elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor.

CAS 82640-04-8 Raloxifene HCl

Raloxifene HCl
(CAS: 82640-04-8)

Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It ...

CAS 50-41-9 Clomifene citrate

Clomifene citrate
(CAS: 50-41-9)

Clomifene Citrate is a selective estrogen receptor modulator used in the treatment of ovulation induction. It is used to treat breast cancer for its antineoplas...

CAS 177583-70-9 ZK 164015

ZK 164015
(CAS: 177583-70-9)

ZK 164015 is a potent estrogen receptor (ER) silent antagonist. ZK 164015 inhibits 17β-estradiol stimulation of luciferase activity (IC50 = 0.025 μM), and inhib...

CAS 182133-25-1 Arzoxifene

Arzoxifene
(CAS: 182133-25-1)

Arzoxifene, also known as LY353381, a synthetic aromatic derivative with anti-estrogenic properties, displays greater bioavailability and higher anti-estrogenic...

CAS 1847-63-8 Nafoxidine HCl

Nafoxidine HCl
(CAS: 1847-63-8)

Nafoxidine HCl is the hydrochloride salt of nafoxidine. Nafoxidine, structurally related to Tamoxifen, is a non-steroidal partial estrogen antagonist.

GDC-0810 (ARN-810)
(CAS: 1365888-06-7)

GDC-0810, also known as ARN-810 and RG6046, an orally bioavailable Selective Estrogen Receptor Degrader (SERD) that demonstrates robust activity in tamoxifen-re...

CAS 129453-61-8 Fulvestrant

Fulvestrant
(CAS: 129453-61-8)

Fulvestrant is an effective inhibitor of the growth of ER-positive MCF-7 (with IC50 of 0.29 nM) but with no effect on the growth of ER-negative BT-20 human brea...

CAS 50-28-2 Estradiol

Estradiol
(CAS: 50-28-2)

Estradiol, or more precisely, 17β-estradiol, is a human sex hormone and steroid, and the primary female sex hormone. It is essential for the maintenance of fert...

CAS 722533-56-4 Elacestrant

Elacestrant
(CAS: 722533-56-4)

Elacestrant, also referred to RAD1901, is a selective and orally available estrogen receptor (ERR) degrader (IC50= 48 and 870 nM for ERα and ERβ, respectively) ...

CAS 434-03-7 Ethisterone

Ethisterone
(CAS: 434-03-7)

Ethisterone is a progestogen hormone being considered to treat prostate cancer.It was the first orally-active progestin.

CAS 2624-43-3 Cyclofenil

Cyclofenil
(CAS: 2624-43-3)

Cyclofenil is a weak non-steroidal selective estrogen receptor modulator (SERM) with ovulation induction properties. It shows higher affinity for estrogen recep...

CAS 190791-29-8 Lasofoxifene tartrate

Lasofoxifene tartrate
(CAS: 190791-29-8)

Lasofoxifene tartrate is the tartrate salt form of Lasofoxifene. Lasofoxifene is a third-generation selective estrogen receptor modulators (SERMs).

CAS 7599-79-3 trans-Clomiphene Citrate

trans-Clomiphene Citrate
(CAS: 7599-79-3)

Enclomiphene citrateis a non-steroidal estrogen receptor antagonist. It can be used for secondary hypogonadism in overweight men wishing to restore normal testi...

CAS 77599-17-8 Panomifene

Panomifene
(CAS: 77599-17-8)

Panomifene is an Estrogen receptor antagonist under the development of Egis Pharmaceuticals. Phase II clinical trials for the treatment of breast cancer was dis...

CAS 50-50-0 Estradiol Benzoate

Estradiol Benzoate
(CAS: 50-50-0)

Estradiol benzoate is an estradiol analog which binds to the human, murine and chicken ERα with IC50 of 22-28 nM.

CAS 849662-80-2 Y 134

Y 134
(CAS: 849662-80-2)

Y 134 is a selective estrogen receptor modulator (SERM) with selectivity for ERα over ERβ (Ki = 0.09 and 11.31 nM, respectively). It has no cross-reactivity wit...

CAS 343248-86-2 ERA63

ERA63
(CAS: 343248-86-2)

A selective agonist of estrogen receptor α

CAS 101574-65-6 GSK 4716

GSK 4716
(CAS: 101574-65-6)

GSK 4716 is a selective agonist of estrogen-related receptors ERRβ and ERRγ displaying selectivity over ERRα and the classical estrogen receptors. Activation of...

CAS 263717-53-9 PPT

PPT
(CAS: 263717-53-9)

PPT, also known as Propyl pyrazole triol, is an ERα selective agonist with a 410-fold relative binding affinity for ERα (49%) versus ERβ (0.12%) and therefore a...

Chemical Structure

CAS 182133-25-1 Arzoxifene

Quick Inquiry

Verification code

Featured Items